Dr. Paczesny's laboratory is internationally recognized for its expertise and achievements in the Hematopoietic Stem Cell Transplantation (HSCT) field. She has pioneered the study of proteomics/biomarkers for complications post allogeneic HSCT and is now transitioning the laboratory work into clinical practice. She also has extensive expertise in the cancer immune tumor microenvironment, inflammation and alarmins, T lymphocyte biology and mechanisms of immunity and tolerance as well as translating novel drug-targetable biomarkers to treatment.